UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. A Randomized, Open-label, Phase II, Multi-center Trial of Gemcitabine (G) with Pazopanib (P) or Gemcitabine (G) with Docetaxel (T) in Previously Treated Subjects with Advanced Soft Tissue Sarcoma
    Mohammed Milhem
  2. A Multicenter Open-Label, Randomized Phase 1b/2, Study of the Bruton
    Brian Link
  3. RTOG 1008: A randomized phase II study of adjuvant concurrent radiation and chemotherapy versus radiation alone in resected high-risk malignant salivary gland tumors
    Mark C. Smith
  4. Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)
    Ayman El-Sheikh
  5. Study to Investigate Ulcerative Colitis
    Steven Polyak
  6. Study to Determine how Patients with Endometrial, Ovarian, Hepatocellular Carcinoma, Carcinoid or Islet Cell Cancer Respond to Treatment
    Mohammed Milhem
  7. Study to Establish Database that will Collect Clinical and Survey Data Outcomes of Head and Neck Squamous Cell Carcinoma
    Nitin Pagedar
  8. Trial for Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
    Ayman El-Sheikh
  9. Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome
    Ayman El-Sheikh
  10. Study of How Women Tolerate Chemotherapy
    David Bender
  11. Effectiveness pf Positron Emission Tomography (PET) Scan on Tumors
    M. Sue O
  12. EVErolimus for Renal Cancer Ensuing Surgical Therapy, a Phase III Study
    Daniel Vaena
  13. Study for Patients with Esophageal or Gastroesophageal Cancer
    Taher Abu Hejleh
  14. Anti-Cancer Activity of Alisertib in Patients with PTCL
    Brian Link
  15. Cell Transplant Study for Multiple Myeloma, POEMS, or Multiple Myeloma with Amyloidosis
    Guido Tricot
  16. Phase 1/2 Study Epigenetic Modification of BRAF-mutated Metastatic Melanoma: Treatment of a Resistant Disease Using Decitabine Combined with Vemurafenib
    Mohammed Milhem
  17. A Phase 1, open-label, multi-center, dose escalation study of the safety, tolerability, pharmacodynamic and pharmacokinetic properties of intravenous GC4419 in combination with radiation and chemother…
    John Buatti
  18. A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide, Bortezomib and Low-Dose Dexamethasone Versus Bortezomib and Low-Dose Dexamethasone in Subjects…
    Sarah Holstein
  19. A Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Effect of Vandetanib on Cellular Markers of Proliferation and Apoptosis in Invasive Breast Cancer
    Ronald Weigel
  20. Phase 1b, Open-label, Multicenter Study of Urelumab (BMS-663513) in Combination with Rituximab in Subjects with Relapsed/Refractory B-Cell Malignancies
    Brian Link

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.